SEC Form 4 · accession 0000899243-15-003174
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William B Stone
Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 14, 2015 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2015 | M | 15,000 | $0.00 | A | 94,175 | D | |
| Common Stock | Aug 13, 2015 | M | 15,000 | $0.00 | A | 109,175 | D | |
| Common StockF4 | Aug 13, 2015 | S | 11,500 | $7.01 | D | 97,675 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | $0.00 | Aug 13, 2015 | M | 15,000 | D | Aug 13, 2015 | Aug 13, 2015 | Common Stock | 15,000 | 0 | D |
| Restricted Stock UnitsF2 | $0.00 | Aug 13, 2015 | M | 15,000 | D | Aug 13, 2015 | — | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on August 12, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended.
- F2The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2016 Annual Meeting of Stockholders.
- F3The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- F4On August 13, 2015, the Reporting Person sold an aggregate of 11,500 shares of the Issuer's Common Stock at a weighted average price of $7.01. The highest sale price for the Common Stock was $7.51 per share and the lowest sale price was $6.84 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.